- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 98,660 | 19.08.24 17:35:57 | +0,210 | +0,21% | 98,580 | 98,640 | 98,270 | 98,660 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 1.076,000 | 20.08.24 10:33:08 | +10,500 | +0,99% | 1.077,000 | 1.086,000 | 1.085,500 | 1.065,500 |
